Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Cullinan Investigative Site, Orlando, Florida Cullinan Investigative Site, Memphis, Tennessee Cullinan Investigative Site, Plano, Texas Cullinan Investigative Site, Webster, Texas Cullinan Investigative Site, Salt Lake City, Utah France
Cullinan Investigative Site, Brest Cullinan Investigative Site, Le Kremlin-Bicêtre Cullinan Investigative Site, Strasbourg Germany
Cullinan Investigative Site, Erlangen Cullinan Investigative Site, Hanover Italy
Cullinan Investigative Site, Roma